2001

Nov 20, 2001
Guidant Notified that Landmark Implantable Defibrillator Study Ends Early

MADIT II Study Stopped Due to 30 Percent Mortality Reduction in Heart Attack Survivors with Implantable Defibrillators Indianapolis, IN and St. Paul, MN - The MADIT II investigative team today...

Nov 14, 2001
Guidant Launches Advanced Stent System in Japan

New Technology Offering Provides Significant Benefit to Second Largest Coronary Stent Market in the World Indianapolis, Ind. and Tokyo, Japan. - Guidant Corporation (NYSE and PCX: GDT), a world...

Nov 13, 2001
Guidant Completes Enrollment Of First Drug-Eluting Stent Trial Utilizing Actinomycin-D

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has completed enrollment...

Nov 12, 2001
Results of Guidant's Next Generation Intravascular Radiotherapy System Clinical Trial Revealed

GALILEO INHIBIT Trial Presented Today at American Heart Association Meeting Indianapolis, Ind. and Anaheim, Calif. - The results of Guidant Corporation's (NYSE and PCX: GDT) GALILEO INHIBIT trial...

Nov 12, 2001
Guidant Commends Cook on Promising Results of Latest Paclitaxel-Coated Stent Trial

Indianapolis, Ind. and Anaheim, Calif. - Guidant Corporation (NYSE and PCX: GDT) congratulated Cook Incorporated on the announcement of Cook's highly positive results from its paclitaxel-coated...

Show 5102550100 per page
Top